Comment on the contribution by Souayah et al., “Guillain–Barré syndrome after Gardasil vaccination: Data from Vaccine Adverse Event Reporting System 2006–2009”

摘要

Souayah et al. recently [1] described reports of Guillain–Barré syndrome (GBS) following the quadrivalent human papillomavirus vaccine (HPV4 or Gardasil~R) received by the United States Vaccine Adverse Event Reporting System (VAERS) during 2006–2009. The authors accessed the publically available VAERS dataset (http://vaers.hhs.gov), and supplemented it with data from the Food and Drug Administration (FDA) under the Freedom of Information Act, but did not fully account for some of the limitations of VAERS in their interpretation of the data.